NCT03378284View on ClinicalTrials.gov

A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 10, 2017

Primary Completion Date

December 23, 2017

Study Completion Date

January 16, 2018

Conditions
PharmacodynamicsHealthy Male Volunteers
Interventions
DRUG

Tegoprazan

Tegoprazan QD for 7 days

DRUG

Revaprazan

Revaprazan QD for 7 days

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT03378284 - A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers | Biotech Hunter | Biotech Hunter